838 related articles for article (PubMed ID: 16802366)
1. Association between enhanced type I collagen expression and epigenetic repression of the FLI1 gene in scleroderma fibroblasts.
Wang Y; Fan PS; Kahaleh B
Arthritis Rheum; 2006 Jul; 54(7):2271-9. PubMed ID: 16802366
[TBL] [Abstract][Full Text] [Related]
2. Trichostatin A prevents the accumulation of extracellular matrix in a mouse model of bleomycin-induced skin fibrosis.
Huber LC; Distler JH; Moritz F; Hemmatazad H; Hauser T; Michel BA; Gay RE; Matucci-Cerinic M; Gay S; Distler O; Jüngel A
Arthritis Rheum; 2007 Aug; 56(8):2755-64. PubMed ID: 17665426
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-29, a key regulator of collagen expression in systemic sclerosis.
Maurer B; Stanczyk J; Jüngel A; Akhmetshina A; Trenkmann M; Brock M; Kowal-Bielecka O; Gay RE; Michel BA; Distler JH; Gay S; Distler O
Arthritis Rheum; 2010 Jun; 62(6):1733-43. PubMed ID: 20201077
[TBL] [Abstract][Full Text] [Related]
4. Bosentan reverses the pro-fibrotic phenotype of systemic sclerosis dermal fibroblasts via increasing DNA binding ability of transcription factor Fli1.
Akamata K; Asano Y; Aozasa N; Noda S; Taniguchi T; Takahashi T; Ichimura Y; Toyama T; Sato S
Arthritis Res Ther; 2014 Apr; 16(2):R86. PubMed ID: 24708674
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of the immunosuppressant FK-506 on human alpha2(I) collagen gene expression and transforming growth factor beta signaling in normal and scleroderma fibroblasts.
Asano Y; Ihn H; Yamane K; Jinnin M; Mimura Y; Tamaki K
Arthritis Rheum; 2005 Apr; 52(4):1237-47. PubMed ID: 15818662
[TBL] [Abstract][Full Text] [Related]
6. Fibroblast expression of the coactivator p300 governs the intensity of profibrotic response to transforming growth factor beta.
Bhattacharyya S; Ghosh AK; Pannu J; Mori Y; Takagawa S; Chen G; Trojanowska M; Gilliam AC; Varga J
Arthritis Rheum; 2005 Apr; 52(4):1248-58. PubMed ID: 15818659
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic regulation of lentiviral transgene vectors in a large animal model.
Hofmann A; Kessler B; Ewerling S; Kabermann A; Brem G; Wolf E; Pfeifer A
Mol Ther; 2006 Jan; 13(1):59-66. PubMed ID: 16140581
[TBL] [Abstract][Full Text] [Related]
8. An increased transforming growth factor beta receptor type I:type II ratio contributes to elevated collagen protein synthesis that is resistant to inhibition via a kinase-deficient transforming growth factor beta receptor type II in scleroderma.
Pannu J; Gore-Hyer E; Yamanaka M; Smith EA; Rubinchik S; Dong JY; Jablonska S; Blaszczyk M; Trojanowska M
Arthritis Rheum; 2004 May; 50(5):1566-77. PubMed ID: 15146427
[TBL] [Abstract][Full Text] [Related]
9. CCAAT binding transcription factor binds and regulates human COL1A1 promoter activity in human dermal fibroblasts: demonstration of increased binding in systemic sclerosis fibroblasts.
Saitta B; Gaidarova S; Cicchillitti L; Jimenez SA
Arthritis Rheum; 2000 Oct; 43(10):2219-29. PubMed ID: 11037881
[TBL] [Abstract][Full Text] [Related]
10. TGF-β-mediated downregulation of microRNA-196a contributes to the constitutive upregulated type I collagen expression in scleroderma dermal fibroblasts.
Honda N; Jinnin M; Kajihara I; Makino T; Makino K; Masuguchi S; Fukushima S; Okamoto Y; Hasegawa M; Fujimoto M; Ihn H
J Immunol; 2012 Apr; 188(7):3323-31. PubMed ID: 22379029
[TBL] [Abstract][Full Text] [Related]
11. Histone deacetylase 7, a potential target for the antifibrotic treatment of systemic sclerosis.
Hemmatazad H; Rodrigues HM; Maurer B; Brentano F; Pileckyte M; Distler JH; Gay RE; Michel BA; Gay S; Huber LC; Distler O; Jüngel A
Arthritis Rheum; 2009 May; 60(5):1519-29. PubMed ID: 19404935
[TBL] [Abstract][Full Text] [Related]
12. Increased levels of transforming growth factor beta receptor type I and up-regulation of matrix gene program: A model of scleroderma.
Pannu J; Gardner H; Shearstone JR; Smith E; Trojanowska M
Arthritis Rheum; 2006 Sep; 54(9):3011-21. PubMed ID: 16947635
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin II in the lesional skin of systemic sclerosis patients contributes to tissue fibrosis via angiotensin II type 1 receptors.
Kawaguchi Y; Takagi K; Hara M; Fukasawa C; Sugiura T; Nishimagi E; Harigai M; Kamatani N
Arthritis Rheum; 2004 Jan; 50(1):216-26. PubMed ID: 14730619
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous downregulation of KLF5 and Fli1 is a key feature underlying systemic sclerosis.
Noda S; Asano Y; Nishimura S; Taniguchi T; Fujiu K; Manabe I; Nakamura K; Yamashita T; Saigusa R; Akamata K; Takahashi T; Ichimura Y; Toyama T; Tsuruta D; Trojanowska M; Nagai R; Sato S
Nat Commun; 2014 Dec; 5():5797. PubMed ID: 25504335
[TBL] [Abstract][Full Text] [Related]
15. Involvement of alphavbeta5 integrin-mediated activation of latent transforming growth factor beta1 in autocrine transforming growth factor beta signaling in systemic sclerosis fibroblasts.
Asano Y; Ihn H; Yamane K; Jinnin M; Mimura Y; Tamaki K
Arthritis Rheum; 2005 Sep; 52(9):2897-905. PubMed ID: 16142753
[TBL] [Abstract][Full Text] [Related]
16. Fli1 Deficiency Induces CXCL6 Expression in Dermal Fibroblasts and Endothelial Cells, Contributing to the Development of Fibrosis and Vasculopathy in Systemic Sclerosis.
Taniguchi T; Asano Y; Nakamura K; Yamashita T; Saigusa R; Ichimura Y; Takahashi T; Toyama T; Yoshizaki A; Sato S
J Rheumatol; 2017 Aug; 44(8):1198-1205. PubMed ID: 28507181
[TBL] [Abstract][Full Text] [Related]
17. EM703, the new derivative of erythromycin, inhibits transcription of type I collagen in normal and scleroderma fibroblasts.
Ikeda H; Sunazuka T; Suzuki H; Hamasaki Y; Yamazaki S; Omura S; Hatamochi A
J Dermatol Sci; 2008 Mar; 49(3):195-205. PubMed ID: 18036782
[TBL] [Abstract][Full Text] [Related]
18. Increased phosphorylation of transcription factor Sp1 in scleroderma fibroblasts: association with increased expression of the type I collagen gene.
Ihn H; Tamaki K
Arthritis Rheum; 2000 Oct; 43(10):2240-7. PubMed ID: 11037883
[TBL] [Abstract][Full Text] [Related]
19. Involvement of the constitutive complex formation of c-Ski/SnoN with Smads in the impaired negative feedback regulation of transforming growth factor beta signaling in scleroderma fibroblasts.
Jinnin M; Ihn H; Mimura Y; Asano Y; Tamaki K
Arthritis Rheum; 2007 May; 56(5):1694-705. PubMed ID: 17469184
[TBL] [Abstract][Full Text] [Related]
20. Monocyte chemoattractant protein 3 as a mediator of fibrosis: Overexpression in systemic sclerosis and the type 1 tight-skin mouse.
Ong VH; Evans LA; Shiwen X; Fisher IB; Rajkumar V; Abraham DJ; Black CM; Denton CP
Arthritis Rheum; 2003 Jul; 48(7):1979-91. PubMed ID: 12847692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
